Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 11, Issue 11, Pages 1509-1523
Publisher
Informa UK Limited
Online
2011-10-20
DOI
10.1586/ern.11.149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tetrabenazine for the Treatment of Tardive Dyskinesia
- (2011) Jonathan G Leung et al. ANNALS OF PHARMACOTHERAPY
- Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors
- (2011) Zhangyu Yao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tourette syndrome: Evolving concepts
- (2011) Joseph Jankovic et al. MOVEMENT DISORDERS
- Management of Huntington’s disease: role of tetrabenazine
- (2011) de Tommaso Therapeutics and Clinical Risk Management
- Role of Tetrabenazine for Huntington's Disease-Associated Chorea
- (2010) L. H. Poon et al. ANNALS OF PHARMACOTHERAPY
- Huntington's disease: From molecular basis to therapeutic advances
- (2010) Sylvia Krobitsch et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Tetrabenazine is neuroprotective in Huntington's disease mice
- (2010) Hongyu Wang et al. Molecular Neurodegeneration
- Tardive dyskinesia and other movement disorders secondary to aripiprazole
- (2010) Maria Sierra Peña et al. MOVEMENT DISORDERS
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
- (2009) Samuel Frank BMC Neurology
- Tetrabenazine
- (2009) Alfonso Fasano et al. EXPERT OPINION ON PHARMACOTHERAPY
- A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles
- (2009) Etienne A. Cartier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2
- (2009) Daniela F. Requena et al. JOURNAL OF NEUROCHEMISTRY
- Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3
- (2009) L. A. Egana et al. JOURNAL OF NEUROSCIENCE
- Treatment of hyperkinetic movement disorders
- (2009) Joseph Jankovic LANCET NEUROLOGY
- Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
- (2009) Thomas S. Guillot et al. MOLECULAR NEUROBIOLOGY
- Tourette??s Syndrome and Role??of??Tetrabenazine
- (2008) Mauro Porta et al. CLINICAL DRUG INVESTIGATION
- A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease
- (2008) Samuel Frank et al. CLINICAL NEUROPHARMACOLOGY
- Deletion of Go2α abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system
- (2008) Irene Brunk et al. FASEB JOURNAL
- Ca2+-dependent Activator Proteins of Secretion Promote Vesicular Monoamine Uptake
- (2008) Irene Brunk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of Weight Gain in Treatments for Tourette Syndrome: Tetrabenazine Versus Neuroleptic Drugs
- (2008) William G. Ondo et al. JOURNAL OF CHILD NEUROLOGY
- Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia
- (2008) Christopher Kenney et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now